Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$10,882,423
+$1,515,999 QoQ
Shares Held
43,246
+0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.20%
of 13F equity value
Holder Rank
#885
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROWLANDMILLER & PARTNERS.ADV holds $61,867,127 across 7 Drug Manufacturers - General names. ABBV ranks #3 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,075 | $18,081,408 | |
| 2 | JNJ |
Johnson & Johnson
|
64,152 | $16,292,683 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
43,246 | $10,882,423 | |
| 4 | AMGN |
Amgen Inc
|
14,748 | $5,340,545 | |
| 5 | MRK |
Merck & Co., Inc.
|
37,007 | $4,755,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
36,350 | $4,592,459 | |
| 7 | PFE |
Pfizer Inc
|
79,826 | $1,922,210 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,882,423 | 43,246 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $9,366,424 | 43,066 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $10,152,496 | 44,433 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,387,810 | 44,864 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $8,445,710 | 45,500 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $9,546,569 | 45,564 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $8,397,924 | 47,259 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $9,325,795 | 47,224 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $8,008,097 | 46,689 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $8,518,455 | 46,779 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $7,288,084 | 47,029 | Shares | Sole | 2024-01-03 | |
| 2023-09-30 | $7,053,072 | 47,317 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $6,406,411 | 47,550 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $7,642,428 | 47,954 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $7,692,312 | 47,598 | Shares | Sole | 2023-01-04 | |
| 2022-09-30 | $6,431,074 | 47,918 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $7,240,945 | 47,277 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,691,633 | 47,447 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $7,579,150 | 55,976 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $155,656 | 1,443 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $4,748,113 | 42,153 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,278,261 | 39,533 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $154,617 | 1,443 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $131,822 | 1,505 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $141,673 | 1,443 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $114,665 | 1,505 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||